Abstract:Objective:To prepare an antibodized HBV vaccine based on HBV PreS2/S and mouse IgG1 Fc fusion molecule,and to analyze the cellular immune response specific against HBV elicited by the vaccine.Methods:The genes coding for HBV PreS2/S and mouse IgG1 Fc were amplified by PCR and cloned into pcDNA3 vector for the construction of the antibodized HBV vaccine. C2C12 cells were transfected with this construct, and HBsAg were detected in transcriptional (RNA) and translational (protein) levels by RT-PCR and ELISA, respectively. Mice were immunized intramuscularly and the proliferative and CTL responses of the splenocytes derived from the immunized mice were analyzed by in vitro lymphoproliferation assay and cytotoxic assay.Results:The construction of the antibodized vaccine was verified to be correct.HBsAg could be expressed detected in the transfected C2C12 cells.Splenocytes derived from the immunized mice exhibited robust proliferation response and stronger CTL response to lyse cells expressing PreS2/S compared to those induced by the conventional HBV recombinant vaccine.Conclusion:The antibodized HBV vaccine based on HBV PreS2/S and mouse IgG1 Fc fusion molecule which can enhance the cellular immune response notably against HBV infection, which might be a promising candidate of therapeutic vaccine to abrogate the immunotolerance of HBV and to treat the chronic hepatitis B patients.

Antibodized gene vaccine harboring to HBV PreS2/S gene can enhance HBV specific CTL response induced by gene immunization